LeMaitre Vascular Inc
NASDAQ:LMAT
Intrinsic Value
LeMaitre Vascular, Inc. engages in the provision of medical devices and human tissue cryopreservation services. [ Read More ]
The intrinsic value of one LMAT stock under the Base Case scenario is 45.6 USD. Compared to the current market price of 67.2 USD, LeMaitre Vascular Inc is Overvalued by 32%.
Valuation Backtest
LeMaitre Vascular Inc
Run backtest to discover the historical profit from buying and selling LMAT stocks based on their intrinsic value.
Analyze the historical link between intrinsic value and market price to make more informed investment decisions.
Fundamental Analysis
Our AI Assistant is coming soon! Stay tuned and thank you for your interest!
Provide an overview
of LeMaitre Vascular Inc's business.
What risks and challenges
does LeMaitre Vascular Inc face in the near future?
Summarize the latest earnings report
of LeMaitre Vascular Inc.
Provide P/E
for LeMaitre Vascular Inc and its competitors.
Balance Sheet Decomposition
LeMaitre Vascular Inc
Current Assets | 194.6m |
Cash & Short-Term Investments | 105.1m |
Receivables | 25.1m |
Other Current Assets | 64.5m |
Non-Current Assets | 152.2m |
PP&E | 39.8m |
Intangibles | 107.7m |
Other Non-Current Assets | 4.7m |
Current Liabilities | 29.9m |
Accounts Payable | 3.7m |
Accrued Liabilities | 25.7m |
Other Current Liabilities | 414k |
Non-Current Liabilities | 19m |
Other Non-Current Liabilities | 19m |
Earnings Waterfall
LeMaitre Vascular Inc
Revenue
|
193.5m
USD
|
Cost of Revenue
|
-66.4m
USD
|
Gross Profit
|
127m
USD
|
Operating Expenses
|
-89.9m
USD
|
Operating Income
|
37.2m
USD
|
Other Expenses
|
-7.1m
USD
|
Net Income
|
30.1m
USD
|
Free Cash Flow Analysis
LeMaitre Vascular Inc
What is Free Cash Flow?
LMAT Profitability Score
Profitability Due Diligence
LeMaitre Vascular Inc's profitability score is 61/100. The higher the profitability score, the more profitable the company is.
Score
LeMaitre Vascular Inc's profitability score is 61/100. The higher the profitability score, the more profitable the company is.
LMAT Solvency Score
Solvency Due Diligence
LeMaitre Vascular Inc's solvency score is 81/100. The higher the solvency score, the more solvent the company is.
Score
LeMaitre Vascular Inc's solvency score is 81/100. The higher the solvency score, the more solvent the company is.
Wall St
Price Targets
LMAT Price Targets Summary
LeMaitre Vascular Inc
According to Wall Street analysts, the average 1-year price target for LMAT is 70.51 USD with a low forecast of 54.54 USD and a high forecast of 88.2 USD.
Ownership
LMAT Insider Trading
Buy and sell transactions by insiders
Period | Sold | Bought | Net |
---|---|---|---|
3 Months |
|
|
|
6 Months |
|
|
|
9 Months |
|
|
|
12 Months |
|
|
|
Shareholder Return
LMAT Price
LeMaitre Vascular Inc
Average Annual Return | 13.14% |
Standard Deviation of Annual Returns | 17.22% |
Max Drawdown | -45% |
Market Capitalization | 1.5B USD |
Shares Outstanding | 22 337 200 |
Percentage of Shares Shorted | 4.43% |
Company Profile
Country
Industry
Market Cap
Dividend Yield
Description
LeMaitre Vascular, Inc. engages in the provision of medical devices and human tissue cryopreservation services. The company is headquartered in Burlington, Massachusetts and currently employs 450 full-time employees. The company went IPO on 2006-10-19. The firm develops, manufactures and markets vascular devices to address the needs of vascular surgeons, and to a lesser degree, other specialties, such as cardiac surgeons, general surgeons and neurosurgeons. The company sold its principal product in the United States, Europe, the United Kingdom, Canada and Asia Pacific. The firm sales its products and services primarily through a direct sales force. Its products and services offering includes Allografts, Angioscopes, Balloon Catheters for Embolectomy and Thrombectomy, Balloon Catheters for Occlusion and Perfusion, Bovine Grafts, Vascular and Cardiac Patches, Carotid Shunts, Closure Systems, Ovine Vascular Grafts, Polyester Vascular Grafts, ePTFE Vascular Grafts, Radiopaque Tape, and Valvulotomes.
Contact
IPO
Employees
Officers
The intrinsic value of one LMAT stock under the Base Case scenario is 45.6 USD.
Compared to the current market price of 67.2 USD, LeMaitre Vascular Inc is Overvalued by 32%.